Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ethnically diverse populations. The complex interplay between beta-amyloid and tau proteins is central to understanding the pathogenesis of AD, yet previous therapeutic strategies have often failed to address these intricacies effectively. Current research highlights the importance of investigating Aß-induced tau pathology across different populations to uncover the root causes of these disparities. Recent studies have begun to explore the molecular underpinnings of AD using multi-omics approaches, which integrate genomics, transcriptomics, proteomics, and metabolomics data. However, there remains a critical need for more comprehensive studies that consider the genetic and environmental diversity of global populations. Addressing these gaps could lead to more effective and inclusive therapeutic strategies, ultimately improving outcomes for individuals affected by AD worldwide.
This research topic aims to highlight the importance of integrating multi-omics data analyses to unravel the molecular mechanisms of Alzheimer’s disease and related dementias across diverse populations. By focusing on the genetic, molecular, and environmental factors that contribute to AD, this research seeks to answer key questions about disease progression and therapeutic intervention. The goal is to identify novel biomarkers, understand genetic and molecular mechanisms, and develop personalized therapeutic approaches tailored to the genetic backgrounds of diverse populations.
To gather further insights in advancing therapeutics for Alzheimer's disease through multi-omics data analysis in ethnically diverse populations, we welcome articles addressing, but not limited to, the following themes:
- Identification of novel biomarkers for Alzheimer's disease and related dementias in diverse populations.
- Investigation of the genetic and molecular mechanisms underlying the progression of Alzheimer's disease in different patient groups.
- Development of personalized therapeutic approaches tailored to the genetic backgrounds of diverse populations.
- Exploration of the role of epigenetic modifications in the pathogenesis and progression of Alzheimer's disease.
- Integration of multi-omics data to elucidate the interactions between genetic, environmental, and lifestyle factors in Alzheimer's disease risk and progression.
Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ethnically diverse populations. The complex interplay between beta-amyloid and tau proteins is central to understanding the pathogenesis of AD, yet previous therapeutic strategies have often failed to address these intricacies effectively. Current research highlights the importance of investigating Aß-induced tau pathology across different populations to uncover the root causes of these disparities. Recent studies have begun to explore the molecular underpinnings of AD using multi-omics approaches, which integrate genomics, transcriptomics, proteomics, and metabolomics data. However, there remains a critical need for more comprehensive studies that consider the genetic and environmental diversity of global populations. Addressing these gaps could lead to more effective and inclusive therapeutic strategies, ultimately improving outcomes for individuals affected by AD worldwide.
This research topic aims to highlight the importance of integrating multi-omics data analyses to unravel the molecular mechanisms of Alzheimer’s disease and related dementias across diverse populations. By focusing on the genetic, molecular, and environmental factors that contribute to AD, this research seeks to answer key questions about disease progression and therapeutic intervention. The goal is to identify novel biomarkers, understand genetic and molecular mechanisms, and develop personalized therapeutic approaches tailored to the genetic backgrounds of diverse populations.
To gather further insights in advancing therapeutics for Alzheimer's disease through multi-omics data analysis in ethnically diverse populations, we welcome articles addressing, but not limited to, the following themes:
- Identification of novel biomarkers for Alzheimer's disease and related dementias in diverse populations.
- Investigation of the genetic and molecular mechanisms underlying the progression of Alzheimer's disease in different patient groups.
- Development of personalized therapeutic approaches tailored to the genetic backgrounds of diverse populations.
- Exploration of the role of epigenetic modifications in the pathogenesis and progression of Alzheimer's disease.
- Integration of multi-omics data to elucidate the interactions between genetic, environmental, and lifestyle factors in Alzheimer's disease risk and progression.